HUTCHMED (China) (HCM) Total Liabilities (2015 - 2026)
HUTCHMED (China) (HCM) posted quarterly Total Liabilities of $461.5 million for Q2 2026, down 13.59% year-over-year from $534.0 million in Q2 2025, and up 615.17% quarter-over-quarter from $64.5 million in Q4 2025.
HUTCHMED (China) (HCM) Total Liabilities (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Total Liabilities for 12 consecutive years, with $461.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Liabilities fell 13.59% year-over-year to $461.5 million; the TTM figure through Jun 2026 stood at $461.5 million (down 13.59% YoY), while the FY2025 annual figure was $64.5 million, changed 0.22% from the prior year.
- Total Liabilities grew to $461.5 million in Q2 2026 per HCM's latest filing, from $64.5 million in the prior quarter.
- Across five years, Total Liabilities topped out at $534.0 million in Q2 2025 and bottomed at $68647.0 in Q4 2023.
- Historically, Total Liabilities has averaged $280.4 million across 5 years, with a median of $342.5 million in 2022.
- Annual changes were most pronounced in 2023 — Total Liabilities slumped 99.86% — and 2024, when it surged 94029.23%.
- HUTCHMED (China)'s Total Liabilities stood at $50.2 million in 2022, then plunged by 99.86% to $68647.0 in 2023, then jumped by 94029.23% to $64.6 million in 2024, then retreated by 0.14% to $64.5 million in 2025, then jumped by 615.17% to $461.5 million in 2026.
- Business Quant data shows HCM's Total Liabilities at $461.5 million in Q2 2026, $64.5 million in Q4 2025, and $534.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | 461.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 461.46 Mn |
| Dec 31, 2025 | 64.52 Mn |
| Jun 30, 2025 | 534.02 Mn |
| Dec 31, 2024 | 64.62 Mn |
| Jun 30, 2024 | 508.85 Mn |
| Dec 31, 2023 | 68,646.96 |
| Jun 30, 2023 | 497.48 Mn |
| Dec 31, 2022 | 50.19 Mn |
| Jun 30, 2022 | 342.48 Mn |
| Dec 31, 2021 | 42.77 Mn |
| Jun 30, 2021 | 259.19 Mn |
| Mar 31, 2021 | 228.72 Mn |
| Dec 31, 2020 | 626.47 Mn |
| Jun 30, 2020 | 158.51 Mn |
| Dec 31, 2019 | 412.12 Mn |
| Sep 30, 2019 | 116.31 Mn |
| Jun 30, 2019 | 122.18 Mn |
| Mar 31, 2019 | 138.94 Mn |
| Dec 31, 2018 | 119.86 Mn |
| Jun 30, 2018 | 120.10 Mn |